Format

Send to

Choose Destination
See comment in PubMed Commons below
Indian J Pharmacol. 2013 Jul-Aug;45(4):325-9. doi: 10.4103/0253-7613.114994.

Development of an in vitro cell culture model to study milk to plasma ratios of therapeutic drugs.

Author information

1
National Institute for Research in Reproductive Health (ICMR), Mumbai, India.

Abstract

OBJECTIVE:

To create an in vitro cell culture model to predict the M/P (concentration of drug in milk/concentration in maternal plasma) ratios of therapeutic drugs viz. rifampicin, theophylline, paracetamol, and aspirin.

MATERIALS AND METHODS:

An in vitro cell culture model using CIT3 cells (mouse mammary epithelial cells) was created by culturing the cells on transwells. The cells formed an integral monolayer, allowing only transcellular transport as it happens in vivo. Functionality of the cells was confirmed through scanning electron microscopy. Time wise transfer of the study drugs from plasma to milk was studied and compared with actual (in vivo) M/P ratios obtained at reported tmax for the respective drugs.

RESULTS:

The developed model mimicked two important intrinsic factors of mammary epithelial cells viz. secretory and tight-junction properties and also the passive route of drug transport. The in vitro M/P ratios at reported tmax were 0.23, 0.61, 0.87, and 0.03 respectively, for rifampicin, theophylline, paracetamol, and salicylic acid as compared to 0.29, 0.65, 0.65, and 0.22, respectively, in vitro.

CONCLUSION:

Our preliminary effort to develop an in vitro physiological model showed promising results. Transfer rate of the drugs using the developed model compared well with the transfer potential seen in vivo except for salicylic acid, which was transferred in far lower concentration in vitro. The model has a potential to be developed as a non-invasive alternative to the in vitro technique for determining the transfer of therapeutic drugs into breast milk.

KEYWORDS:

CIT3 cells; Cell culture; M/P ratios; in vitro; milk-plasma ratio; reversed phase-High performance liquid chromatography

PMID:
24014904
PMCID:
PMC3757597
DOI:
10.4103/0253-7613.114994
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
    Loading ...
    Support Center